tirzepatide meta analysis Carolina Aldana NP-PHC, BScN, MN, DNP(c) | 🌿 These medications may be doing more than we once thought. A 2025 systematic review and meta-analysis found that — a dual Pancreatic Safety of Tirzepatide and

Semaglutides cardiovascular benefits, as demonstrated in diabetes management trials, may extend to individuals with PCOS, offering additional protection against cardiovascular risks associated with the condition

The Bottom Line Brand-name and compounded tirzepatide deliver the same active ingredient through different regulatory pathways

If pharmacological treatment for anxiety becomes necessary, selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) are preferred, with consideration for more weight-neutral options when possible

Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study